Filing Details

Accession Number:
0001209191-21-048271
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-27 06:00:14
Reporting Period:
2021-07-26
Accepted Time:
2021-07-27 06:00:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1394319 Tracon Pharmaceuticals Inc. TCON () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1265784 R William Larue 4350 La Jolla Village Drive
Suite 800
San Diego CA 92122
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-07-26 6,545 $3.82 7,883 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. On November 7, 2019, the Issuer effected a 10 for 1 reverse split of its common stock, upon which the reporting person's ownership was reduced by 12,050 shares of common stock.